Essential Science works with a range of industry leading technology companies. Some examples of current and past clients include:
a2sp Ltd
UK | Commercialisation of technology for immobilisation and screening of small and macromolecules |
| Acadia, USA, Sweden | Provision of CMC development support |
Ajinomoto
Japan | Technologies to enhance mammalian cell culture and downstream processing of protein therapeutics |
| BioAgency/Novologix, Germany | Licensing novel, validated bacterial target (G-ve and G+ve) and screening assay |
| Biothera, USA | Supporting licensing and co-development opportunities for a cotherapy in oncology |
| Confidential, Denmark | Supporting preclinical pharmaceutical development strategy and planning |
| Confidential, Korea | Supporting corporate development strategy, pharmaceutical API and fine chemicals |
| Confidential, Switzerland | Business development and licensing support, biologics-biomaterials combination therapies |
| Confidential, USA | Cotherapy opportunity in infectious disease and wound healing |
| Dextra, UK | Commercialisation of carbohydrate synthesis technology |
Dompé pha.r.ma
Italy | Collaborative development of protein therapeutics in oncology |
Dompé pha.r.ma
Italy | In licensing and collaborative development of technologies for secondary manufacture |
Fleet Bioprocessing
UK | Protein conjugation technology and linkers for antibody drug conjugates |
Life Science Consulting
Switzerland | Commercialisation of on-line database facility for pharmaceutical deal tracking, valuation and modelling |
Phosphonics Ltd
UK | Novel functionalized materials for purification, metal scavenging and heterogeneous catalysis |
Prolysis Ltd
Oxford, UK | Collaborative discovery and development of small molecule antibiotics |
